Tid Tittel Kategori Vedlegg
14.08.2026
17:45
 Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II -
1
11.08.2026
08:00
 Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S. -
1
07.08.2026
18:03
 Photocure ASA: Notification of primary insider transactions INSIDEHANDEL INS
2
07.08.2026
18:00
 Photocure ASA - Share option grant to members of the board of directors INSIDEHANDEL INS
2
04.08.2026
08:00
 Photocure ASA: Asieris counterclaim on milestone payment arbitration INFORMASJON INF -
29.07.2026
21:48
 Photocure ASA - Share option grant INSIDEHANDEL INS
2
29.07.2026
08:00
 Photocure ASA: Results for the second quarter of 2026 RAPPORT RAP
3
22.07.2026
08:56
 Photocure ASA: Invitation to presentation of second quarter 2026 financial results -
1
14.07.2026
08:07
 Photocure ASA - Share option grant -
1
30.06.2026
15:31
 Photocure ASA - CFO transition -
1
26.06.2026
19:18
 Photocure ASA: Annual general meeting held -
2
08.06.2026
18:09
 Photocure and Artera to partner on digital pathology AI test evaluation for Bladder Cancer -
1
05.06.2026
14:56
 Photocure ASA - Notice of the Annual General Meeting 26 June 2026 -
6
04.06.2026
16:30
 Photocure ASA to Acquire Vesica Health Inc., Strengthening Leadership in Bladder Cancer Diagnostics INFORMASJON INF
2
18.05.2026
17:00
 AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study -
1
07.05.2026
07:00
 Photocure ASA: Results for the first quarter of 2026 RAPPORT RAP
3
04.05.2026
08:00
 New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer -
1
30.04.2026
09:00
 Photocure ASA: Invitation to presentation of first quarter 2026 financial results -
1
27.04.2026
09:00
 Photocure ASA: Annual Report 2025 RAPPORT RAP
3
20.04.2026
16:31
 Photocure ASA: Update on milestone payments from Asieris Pharmaceuticals INFORMASJON INF -
13.04.2026
08:30
 Photocure ASA: Update on Regulatory Classification for OAY Equipment -
1
16.03.2026
17:00
 Photocure: Trials in Progress presented at the European Association of Urology (EAU) 2026 congress aim to enable a more personalized bladder cancer care pathway -
1
03.03.2026
10:35
 Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions -
1
18.02.2026
07:00
 Photocure ASA: Results for the fourth quarter of 2025 RAPPORT RAP
3
11.02.2026
17:06
 Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results - -